RecruitingNot ApplicableNCT06306183

Effect of Vitamin C on Pain Reduction After an Emergency Department Visit

Vitamin C for Acute Musculoskeletal Pain in Emergency Department Patients: A Triple-Blind Randomized Control Trial (VICAMED)


Sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Enrollment

204 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Musculoskeletal (MSK) injuries such as sprains, strains, bruises, and fractures are among the most common reasons people visit the emergency department. These injuries often cause significant pain in the first few days, making it difficult to move, work, or sleep. Usual pain medications like ibuprofen or acetaminophen can help, but they are not safe or effective for everyone. Some people cannot take them because of heart, kidney, stomach, or liver problems. Others still experience strong pain despite treatment. Because of these limits, some patients receive opioids, which can cause side effects and carry a risk of dependence. Safer and more accessible options are needed. Vitamin C is widely known for supporting the immune system, but research suggests it may also help reduce pain and inflammation. Studies in surgical patients have shown that vitamin C can lower pain levels, reduce the need for opioids, and support healing. These effects may be linked to its antioxidant properties and its role in tissue repair. However, no study has tested whether vitamin C can help people with recent MSK injuries treated in the emergency department. The VICAMED study aims to answer this question. Adults arriving with an MSK injury that occurred within the past 48 hours can participate if they have at least moderate pain. Participants are randomly assigned to receive either vitamin C or a placebo. The first dose is given in the emergency department, followed by twice daily capsules for three days. Pain is measured using a simple 0-100 scale, recorded in an electronic or paper diary. A follow-up on day six helps the research team understand each participant's recovery, medication use, and overall experience. Vitamin C is inexpensive, widely available, and very safe at the doses used in this study. If it proves effective, it could offer a simple, low risk option to help patients manage pain after an MSK injury and reduce the need for opioids in emergency care.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age ≥ 18 years old
  • Presenting to the ED with acute MSK pain of ≤ 48 hours duration at triage
  • Verbal numerical rating scale pain intensity at triage of ≥ 4 on a 0-10 scale
  • Triaged to the ambulatory section of the ED
  • Able to communicate in French or English

Exclusion Criteria9

  • Usage of Vit C supplements in the last week
  • Active cancer
  • Treated with opioids for any pain within 24 hours prior to recruitment
  • Treatment for chronic pain
  • Unable to fill out a pain intensity diary or unavailable for follow-up
  • Allergy to milk (lactose in the placebo) or Vit C
  • Treated with cyclosporine or warfarin
  • Pre-existing oxalate nephropathy, liver cirrhosis or hemochromatosis
  • Hospitalized after clinician evaluation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTVitamin C

900 mg vitamin C taken orally twice a day (one in the morning and one in the evening) for a 3-day period after ED discharge for the treatment arm.

OTHERPlacebo

Placebo taken orally twice a day (one in the morning and one in the evening) for a 3-day period after ED discharge for the treatment arm.


Locations(4)

The Ottawa Hospital - General and Civic Campus

Ottawa, Ontario, Canada

Hôtel-Dieu de Lévis

Lévis, Quebec, Canada

Hopital du Sacre-Coeur de Montreal

Montreal, Quebec, Canada

CHU de Québec - Université Laval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06306183


Related Trials